|
|
|
Volumn 50, Issue 11, 2001, Pages 928-929
|
|
What are the current treatment and monitoring recommendations for hepatitis C virus (HCV)?
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
RIBAVIRIN;
VIRUS RNA;
CASE REPORT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
GENOTYPE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
MONITORING;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
VIRUS LOAD;
DISEASE PROGRESSION;
DRUG MONITORING;
EVIDENCE-BASED MEDICINE;
GENOTYPE;
HEPATITIS C;
HUMANS;
LIVER FUNCTION TESTS;
PATIENT SELECTION;
PRACTICE GUIDELINES;
PREDICTIVE VALUE OF TESTS;
PRIMARY HEALTH CARE;
PROGNOSIS;
TREATMENT OUTCOME;
VIRAL LOAD;
|
|
EID: 0035169273
PISSN: 00943509
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (8)
|
